dollars / greg,agree entirely. cash on hand and research credits...

dollars / greg,

agree entirely. cash on hand and research credits cover us for 2 quarters. 3 at best.

the october target date for fuji eats into one of those quarters. yes this could come sooner, but more problematically could also come later..... if i was fuji i would be dragging my feet.

language around fuji suitably short and flat, which is likely prudent but could also be slightly concerning (i am sure it has been more bullish previously?)

if there is any real disappointment it is the stated focus on direct to market over new oems. makes sense in the long term i guess, but like others i am more than ready for a little sugar hit as well.

the fact that the growth in lab sites line on the graph remains linear and not bending up also slightly disappointing. BCT really needs to start hitting expotential growth if revenues (and profits) are to start exceeding costs.

gltah
the w